| Literature DB >> 21807794 |
Lilian H D van Tuyl1, Josef S Smolen, George A Wells, Marieke Scholte-Voshaar, Wijnanda Hoogland, Maarten Boers.
Abstract
Absence of disease activity, or remission, is the most important treatment goal for patients with rheumatoid arthritis (RA). Since a new preliminary definition of remission in RA for clinical trials has been proposed, we investigated what determinants of disease activity patients associate with a state of remission and whether dimensions of impact of disease on daily life are involved. Our report summarizes progress of a workshop at OMERACT 10 on the patient perspective on remission in RA, including the results of a short pre-conference survey among patients, the discussions among the participants and a research agenda resulting from these discussions. This initial OMERACT workshop on remission from the patient perspective showed that there is a great interest among patients, physicians, and researchers to study the concept of remission, taking into account measures that patients indicate as important, but that there is a lack of data on appropriate measures, resulting in a considerable research agenda.Entities:
Mesh:
Year: 2011 PMID: 21807794 DOI: 10.3899/jrheum.110394
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666